Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haichen Yang

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Epilepsia|August 26, 2009
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trialPaul M Levisohn, Mark Mintz, Scott J Hunter, et al.
Epilepsy Research|December 15, 2015
Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysisTracy Glauser, Antonio Laurenza, Haichen Yang, et al.
Epilepsy & Behavior : E&B|August 23, 2017
Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggressionSteve Chung, Betsy Williams, Cindy Dobrinsky, et al.
Biologics : Targets & Therapy|March 3, 2025
Berberine Intervention Mitigates Myocardial Ischemia-Reperfusion Injury in a Rat Model: Mechanistic Insights via miR-184 SignalingHaichen Yang, Gang Cao, Xia Li, et al.
Chemosphere|March 17, 2024
The unique biodegradation pathway of benzo[a]pyrene in moderately halophilic Pontibacillus chungwhensis HN14Zhihui Qian, Haichen Yang, Jin Li, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorderHerman G M Westenberg, Dan J Stein, Haichen Yang, et al.
Epilepsy Research|September 7, 2016
Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizuresVicente Villanueva, Oneeb Majid, Charcrin Nabangchang, et al.
Epilepsy Research|January 25, 2015
Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trialsIlo E Leppik, Robert T Wechsler, Betsy Williams, et al.
The International Journal of Neuropsychopharmacology|November 8, 2003
Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trialDan J Stein, Herman G M Westenberg, Haichen Yang, et al.
Epilepsia|July 4, 2015
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanelAlan B Ettinger, Antonia LoPresti, Haichen Yang, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Epilepsia|August 26, 2009
Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trialPaul M Levisohn, Mark Mintz, Scott J Hunter, et al.
Epilepsy Research|December 15, 2015
Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysisTracy Glauser, Antonio Laurenza, Haichen Yang, et al.
Epilepsy & Behavior : E&B|August 23, 2017
Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggressionSteve Chung, Betsy Williams, Cindy Dobrinsky, et al.
Biologics : Targets & Therapy|March 3, 2025
Berberine Intervention Mitigates Myocardial Ischemia-Reperfusion Injury in a Rat Model: Mechanistic Insights via miR-184 SignalingHaichen Yang, Gang Cao, Xia Li, et al.
Chemosphere|March 17, 2024
The unique biodegradation pathway of benzo[a]pyrene in moderately halophilic Pontibacillus chungwhensis HN14Zhihui Qian, Haichen Yang, Jin Li, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorderHerman G M Westenberg, Dan J Stein, Haichen Yang, et al.
Epilepsy Research|September 7, 2016
Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizuresVicente Villanueva, Oneeb Majid, Charcrin Nabangchang, et al.
Epilepsy Research|January 25, 2015
Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trialsIlo E Leppik, Robert T Wechsler, Betsy Williams, et al.
The International Journal of Neuropsychopharmacology|November 8, 2003
Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trialDan J Stein, Herman G M Westenberg, Haichen Yang, et al.
Epilepsia|July 4, 2015
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanelAlan B Ettinger, Antonia LoPresti, Haichen Yang, et al.
Pageof 8